Safety of ACEi and ARB in COVID-19 management: A retrospective analysis.

Sabina Kumar Mastaneh Nikravesh Chukwuemeka Anthony Umeh Michael Randazzo Peter Flores Prithi Choday Ajith Raja Mahendra Aseri Shah ShivangSumanta ChaudhuriPranav Barve

Published in: Clinical cardiology (2022)

Our results are consistent with the clinical guidelines and position statements per the International Society of Hypertension, that there is no indication to stop the use of ACEi/ARB in COVID-19 patients.

Keyphrases

sars cov
coronavirus disease
blood pressure
clinical practice
respiratory syndrome coronavirus